Medical Data Firm Tempus AI Meets Goal in $410.7 Million IPO (1)

Tempus AI Inc., a technology platform company using artificial intelligence to process medical data, priced its initial public offering at the top of a marketed range to raise $410.7 million.

Joining a rush of companies going public while touting their AI credentials, Tempus sold 11.1 million shares for $37 each after offering them for $35 to $37, according to a statement Thursday confirming an earlier report by Bloomberg News.

At the IPO price, the company has a market value of $6.1 billion based on the outstanding shares listed in its filings with the US Securities and Exchange Commission.

Chicago-based ...